Cargando…

Changes in diagnosis and operative treatment of insulinoma over two decades

PURPOSE: Most insulinomas are small solitary, benign neoplasms. Imaging and surgical techniques improved over the last 20 years. Thus, the aim of the present study was to analyze changes in diagnosis and surgery of insulinoma patients in a referral center over two decades. METHODS: Operated patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiese, D., Humburg, F. G., Kann, P. H., Rinke, A., Luster, M., Mahnken, A., Bartsch, D. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310606/
https://www.ncbi.nlm.nih.gov/pubmed/37386194
http://dx.doi.org/10.1007/s00423-023-02974-6
_version_ 1785066576537452544
author Wiese, D.
Humburg, F. G.
Kann, P. H.
Rinke, A.
Luster, M.
Mahnken, A.
Bartsch, D. K.
author_facet Wiese, D.
Humburg, F. G.
Kann, P. H.
Rinke, A.
Luster, M.
Mahnken, A.
Bartsch, D. K.
author_sort Wiese, D.
collection PubMed
description PURPOSE: Most insulinomas are small solitary, benign neoplasms. Imaging and surgical techniques improved over the last 20 years. Thus, the aim of the present study was to analyze changes in diagnosis and surgery of insulinoma patients in a referral center over two decades. METHODS: Operated patients with a histologically proven insulinoma were retrieved from a prospective database. Clinico-pathological characteristics and outcomes were retrospectively analyzed with regard to the time periods 2000–2010 (group 1) and 2011–2020 (group 2). RESULTS: Sixty-one of 202 operated patients with pNEN had an insulinoma, 37 (61%) in group 1 and 24 (39%) in group 2. Of those 61 insulinomas, 49 (80%) were sporadic benign, 8 (13%) benign MEN1-associated insulinomas, and 4 (7%) sporadic malignant insulinomas. In 35 of 37 (95%) patients of group 1 and all patients of group 2, the insulinoma was preoperatively identified by imaging. The most sensitive imaging modality was endoscopic ultrasound (EUS) with correctly diagnosed and localized insulinomas in 89% of patients in group 1 and 100% in group 2. In group 1, significantly less patients were operated via minimally invasive approach compared to group 2 (19% (7/37) vs. 50% (12/24), p = 0.022). Enucleation was the most frequently performed operation (31 of 61, 51%), followed by distal resection (15 of 61, 25%) without significant differences between groups 1 and 2. The rate of relevant postoperative complications was not different between groups 1 and 2 (24% vs. 21%, p = 0.99). Two patients with benign insulinoma (1 out of each group) experienced disease recurrence and underwent a second resection. After a median follow-up of 134 (1–249) months, however, all 57 (100%) patients with benign insulinoma and 3 out of 4 patients with malignant insulinoma had no evidence of disease. CONCLUSION: Insulinoma can be preoperatively localized in almost all patients, allowing for a minimally invasive, parenchyma-sparing resection in selected patients. The long-term cure rate is excellent.
format Online
Article
Text
id pubmed-10310606
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103106062023-07-01 Changes in diagnosis and operative treatment of insulinoma over two decades Wiese, D. Humburg, F. G. Kann, P. H. Rinke, A. Luster, M. Mahnken, A. Bartsch, D. K. Langenbecks Arch Surg Research PURPOSE: Most insulinomas are small solitary, benign neoplasms. Imaging and surgical techniques improved over the last 20 years. Thus, the aim of the present study was to analyze changes in diagnosis and surgery of insulinoma patients in a referral center over two decades. METHODS: Operated patients with a histologically proven insulinoma were retrieved from a prospective database. Clinico-pathological characteristics and outcomes were retrospectively analyzed with regard to the time periods 2000–2010 (group 1) and 2011–2020 (group 2). RESULTS: Sixty-one of 202 operated patients with pNEN had an insulinoma, 37 (61%) in group 1 and 24 (39%) in group 2. Of those 61 insulinomas, 49 (80%) were sporadic benign, 8 (13%) benign MEN1-associated insulinomas, and 4 (7%) sporadic malignant insulinomas. In 35 of 37 (95%) patients of group 1 and all patients of group 2, the insulinoma was preoperatively identified by imaging. The most sensitive imaging modality was endoscopic ultrasound (EUS) with correctly diagnosed and localized insulinomas in 89% of patients in group 1 and 100% in group 2. In group 1, significantly less patients were operated via minimally invasive approach compared to group 2 (19% (7/37) vs. 50% (12/24), p = 0.022). Enucleation was the most frequently performed operation (31 of 61, 51%), followed by distal resection (15 of 61, 25%) without significant differences between groups 1 and 2. The rate of relevant postoperative complications was not different between groups 1 and 2 (24% vs. 21%, p = 0.99). Two patients with benign insulinoma (1 out of each group) experienced disease recurrence and underwent a second resection. After a median follow-up of 134 (1–249) months, however, all 57 (100%) patients with benign insulinoma and 3 out of 4 patients with malignant insulinoma had no evidence of disease. CONCLUSION: Insulinoma can be preoperatively localized in almost all patients, allowing for a minimally invasive, parenchyma-sparing resection in selected patients. The long-term cure rate is excellent. Springer Berlin Heidelberg 2023-06-29 2023 /pmc/articles/PMC10310606/ /pubmed/37386194 http://dx.doi.org/10.1007/s00423-023-02974-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Wiese, D.
Humburg, F. G.
Kann, P. H.
Rinke, A.
Luster, M.
Mahnken, A.
Bartsch, D. K.
Changes in diagnosis and operative treatment of insulinoma over two decades
title Changes in diagnosis and operative treatment of insulinoma over two decades
title_full Changes in diagnosis and operative treatment of insulinoma over two decades
title_fullStr Changes in diagnosis and operative treatment of insulinoma over two decades
title_full_unstemmed Changes in diagnosis and operative treatment of insulinoma over two decades
title_short Changes in diagnosis and operative treatment of insulinoma over two decades
title_sort changes in diagnosis and operative treatment of insulinoma over two decades
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310606/
https://www.ncbi.nlm.nih.gov/pubmed/37386194
http://dx.doi.org/10.1007/s00423-023-02974-6
work_keys_str_mv AT wiesed changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT humburgfg changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT kannph changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT rinkea changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT lusterm changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT mahnkena changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades
AT bartschdk changesindiagnosisandoperativetreatmentofinsulinomaovertwodecades